-
Meis transcription factors regulate cardiac conduction system development and adult function Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-17 Noelia Muñoz-Martín, Ana Simon-Chica, Covadonga Díaz-Díaz, Vanessa Cadenas, Susana Temiño, Isaac Esteban, Andreas Ludwig, Barbara Schormair, Juliane Winkelmann, Veronika Olejnickova, David Sedmera, David Filgueiras-Rama, Miguel Torres
Aims The Cardiac Conduction System (CCS) is progressively specified during development by interactions among a discrete number of Transcriptions Factors that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain transcription factors (TFs) with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations
-
SerpinB1 targeting safeguards against pathological cardiac hypertrophy and remodelling by suppressing cardiomyocyte pyroptosis and inflammation initiation Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-17 Cong Lan, Gangyao Fang, Xiuchuan Li, Xiao Chen, Yingmei Chen, Tao Hu, Xuenan Wang, Huiling Cai, Jiajin Hao, Haoran Li, Yan Zhang, Ke Peng, Zaicheng Xu, Dachun Yang, Xia Kang, Qian Xin, Yongjian Yang
Aims While the pivotal role of inflammation in pathological cardiac hypertrophy and remodelling is widely acknowledged, the mechanisms triggering inflammation initiation remain largely obscure. This study aims to elucidate the role and mechanism of serpin family B member 1 (SerpinB1) in pro-inflammatory cardiomyocyte pyroptosis, heart inflammation, and cardiac remodelling. Methods and results C57BL/6J
-
Correction to: Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-16
-
CXCR4-targeted sensitive magnetic particle imaging for abdominal aortic aneurysm early detection and prognosis evaluation by recognizing total inflammatory cells Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-11 Genmao Cao, Ruijing Zhang, Xiaohua Jia, Jiang Bo, Yaling Li, Xuezhen Xuan, Jie Tian, Hui Hui, Shijie Xin, Honglin Dong
Background The maximum aortic diameter remains the diagnostic criteria and the indicator for prognosis prediction of abdominal aortic aneurysms (AAA). An additional imaging modality is currently needed to help evaluate the prognosis of AAA as well as early detection of AAA formation. This study evaluated the most effective inflammatory markers for AAA using single-cell sequencing and, from these, developed
-
Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischemic injury involves direct activation of mitochondrial sirtuin 3 Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-11 Ahmed M Darwesh, Liye Fang, Tariq R Altamimi, K Lockhart Jamieson, Wesam Bassiouni, Robert Valencia, Andy Huang, Faqi Wang, Hao Zhang, Marawan Ahmed, Keshav Gopal, Yongneng Zhang, Evangelos D Michelakis, John R Ussher, Matthew L Edin, Darryl C Zeldin, Khaled Barakat, Gavin Y Oudit, Zamaneh Kassiri, Gary D Lopaschuk, John M Seubert
Aims Although current clinical therapies following myocardial infarction have improved patient outcomes, morbidity, and mortality rates secondary to ischemic and ischemia reperfusion (IR) injury remains high. Maintaining mitochondrial quality is essential to limit myocardial damage following cardiac ischemia and IR injury. The mitochondrial deacetylase sirtuin 3 (SIRT3) plays a pivotal role in regulating
-
The m6A demethylase ALKBH5 is a novel epigenetic regulator of aortic valve calcification Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-11 Yueheng Wang, Shengping He, Lan Lan, Hongjiao Yu, Huan Zhao, Yuchen Xie, Guoli Zhong, Liang Yuan, Kun Li, Xiao Hu, Vicky E Macrae, Xiaodong Fu, Guojun Chen, Dongxing Zhu
Aims Calcific aortic valve disease (CAVD) is a common heart valve disease with significant clinical consequences. The mechanisms that drive the pathogenesis of CAVD remain to be fully elucidated. N6-methyladenosine (m6A), the most prevalent RNA epigenetic regulator, has recently been implicated in cardiovascular disease, but its role in CAVD has yet to be investigated. In this study, we investigated
-
NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-10 Anna Zoccarato, Ioannis Smyrnias, Christina M Reumiller, Anne D Hafstad, Mei Chong, Daniel A Richards, Celio X C Santos, Asjad Visnagri, Sharwari Verma, Daniel I Bromage, Min Zhang, Xiaohong Zhang, Greta Sawyer, Richard Thompson, Ajay M Shah
Aims The transcription factor NRF2 is well recognized as a master regulator of antioxidant responses and cytoprotective genes. Previous studies showed that NRF2 enhances resistance of mouse hearts to chronic hemodynamic overload at least in part by reducing oxidative stress. Evidence from other tissues suggests that NRF2 may modulate glucose intermediary metabolism but whether NRF2 has such effects
-
When cell mechanics meets epitranscriptomics: reduction of m6A in Piezo2 RNA ameliorates cardiac fibrosis. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-03 Gloria Garoffolo,Maurizio Pesce
-
-
Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-21 Karm A Alhasan, Melissa A King, Badal S B Pattar, Ian A Lewis, Gary D Lopaschuk, Steven C Greenway
Heart failure (HF) is a complex syndrome and a leading cause of mortality worldwide. While current medical treatment is based on known pathophysiology and is effective for many patients, the underlying cellular mechanisms are poorly understood. Energy deficiency is a characteristic of HF, marked by complex alterations in metabolism. Within the tricarboxylic acid cycle, anaplerosis emerges as an essential
-
On the cusps of the second heart field: insights from zebrafish into arterial valve origins and disease. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-21 Robert G Kelly
-
TGF-β signalling: the Dr. Jekyll and Mr. Hyde of the aortic aneurysms. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-19 Sara Perrotta,Daniela Carnevale,Giuseppe Lembo
-
C-C motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-18 Naoki Tsuboya, Hirofumi Sawada, Yoshihide Mitani, Hironori Oshita, Kazunobu Ohya, Mami Takeoka, Jane Chanda Kabwe, Yoshiki Miyasaka, Hiromasa Ito, Noriko Yodoya, Hiroyuki Ohashi, Junko Maruyama, Ryuji Okamoto, Tomoji Mashimo, Kaoru Dohi, Yuhei Nishimura, Kazuo Maruyama, Masahiro Hirayama
Aims We investigated whether the disruption of C-C motif chemokine receptor (CCR) 2 may attenuate the development of pulmonary arterial hypertension (PAH) in any rat models with the reversal of the associated pro-inflammatory state and vascular dysfunction, and synergize with a conventional pulmonary vasodilator. Methods and Results Using Ccr2(-/-) rats generated by CRISPR/Cas9, we investigated pulmonary
-
Inflammation and heart failure: are we facing a "hedgehog's dilemma"? Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-16 Stefano Ministrini,Giovanni G Camici
-
Regulation of blood pressure by METTL3 via RUNX1b-eNOS pathway in endothelial cells in mice Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-12 Yanhong Zhang, Xiaoxiao Yang, Mei Lan, Ze Yuan, Shuai Li, Yangping Liu, Cha Han, Ding Ai, Yang Yang, Yi Zhu, Bochuan Li
Aims Endothelial cells regulate vascular tone to control the blood pressure (BP) by producing both relaxing and contracting factors. Previously, we identified methyltransferase-like 3 (METTL3), a primary N6-methyladenosine (m6A) methyltransferase, as a key player in alleviating endothelial atherogenic progression. However, its involvement in BP regulation remains unclear. Methods and results To evaluate
-
Inflammaging, a targetable pathway for preventing cardiovascular diseases Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-12 Juan Francisco Aranda, Cristina M Ramírez, María Mittelbrunn
Inflammaging, characterized by persistent chronic inflammation in older adults, has emerged as a critical factor linked to age-related diseases such as cardiovascular diseases (CVDs), metabolic disorders, and cognitive decline, which collectively contribute to the leading causes of death globally. Elevated levels of cytokines, chemokines, and others inflammatory mediators characterize inflammaging
-
miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissues Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-11 Giorgia Senesi, Alessandra M Lodrini, Shafeeq Mohammed, Simone Mosole, Jesper Hjortnaes, Rogier J A Veltrop, Bela Kubat, Davide Ceresa, Sara Bolis, Andrea Raimondi, Tiziano Torre, Paolo Malatesta, Marie-José Goumans, Francesco Paneni, Giovanni G Camici, Lucio Barile, Carolina Balbi, Giuseppe Vassalli
Background and Aims Cardiac fibrosis in response to injury leads to myocardial stiffness and heart failure. At the cellular level, fibrosis is triggered by the conversion of cardiac fibroblasts (CF) into extracellular matrix–producing myofibroblasts. miR-24-3p regulates this process in animal models. Here, we investigated whether miR-24-3p plays similar roles in human models. Methods and Results Gain–
-
-
Temporal changes in mediation effects on cardiovascular and microvascular outcomes with glucagon-like peptide-1 receptor agonist therapy: a post-hoc analysis of the LEADER trial. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Zi-Yang Peng,Yu-Hsuan Lee,Huang-Tz Ou,Shihchen Kuo
-
Causal cardiovascular risk factors for dementia – insights from observational and genetic studies Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Emilie Westerlin Kjeldsen, Ruth Frikke-Schmidt
The escalating prevalence of dementia worldwide necessitates preventive strategies to mitigate its extensive health, psychological, and social impacts. As the prevalence of dementia continues to rise, gaining insights into its risk factors and causes become paramount, given the absence of a definitive cure. Cardiovascular disease has emerged as a prominent player in the complex landscape of dementia
-
Neuroimmune cross-talk in heart failure Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Sabrina Montuoro, Francesco Gentile, Alberto Giannoni
Heart failure (HF) is characterized by autonomic nervous system (ANS) imbalance and low-grade chronic inflammation. The bidirectional relationship between the ANS and immune system (IS) is named “neuroimmune cross-talk” (NICT), and is based on common signaling molecules, receptors, and pathways. NICT may be altered in HF, and neuroinflammation seems to be a main driver of HF progression. In HF, heightened
-
Epitranscriptomic regulation of cardiac fibrosis via YTHDF1-dependent PIEZO2 mRNA m6A modification Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Ji-Fei Ding, Bin Tu, Kai Song, Zhen-Yu Liu, Li-Chan Lin, Zhi-Yan Liu, Yan Shi, Jing-Jing Yang, Jian-Yuan Zhao, Hui Tao
Background Mechanosensitive ion channels play a key role in heart development, physiology, and disease. However, little is known about the molecular mechanisms of the mechanosensitive nonselective cationic channel Piezo family in cardiac fibrosis. Methods and Results Mice were treated with ISO/Ang-II/TAC to induce cardiac fibrosis. AAV9 carrying POSTN promoter-driven small hairpin RNA targeting YTHDF1
-
PINK1-mediated mitophagy attenuates pathological cardiac hypertrophy by suppressing the mtDNA release-activated cGAS-STING pathway Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Haobin Zhou, Xiao Wang, Tianyu Xu, Daojing Gan, Zhuang Ma, Hao Zhang, Jian Zhang, Qingchun Zeng, Dingli Xu
Aims Sterile inflammation is implicated in the development of heart failure (HF). Mitochondria plays important roles in triggering and maintaining inflammation. Mitophagy is important for regulation of mitochondrial quality and maintenance of cardiac function under pressure overload. The association of mitophagy with inflammation in HF is largely unclear. As PINK1 is a central mediator of mitophagy
-
The history of science captured in paintings: what modern scientists can learn by studying the history of science? Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Gerard Pasterkamp,Tomasz J Guzik
-
Tackling change: menopause as a cardiovascular disease risk factor and the path to health equity. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-14 W Glen Pyle
-
Minimizing gut microbiome confounding factors in cardiovascular research. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-04 Rikeish R Muralitharan,Jan W Buikema,Francine Z Marques
-
Erbb3 and Hspa2, two novel predictors of heart failure in diabetic patients. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-04 Maurizio Forte,Mattia Galli,Sebastiano Sciarretta
-
Advances in myocardial energy metabolism: metabolic remodeling in heart failure and beyond Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-25 Qiuyu Sun, Qutuba G Karwi, Nathan Wong, Gary D Lopaschuk
The very high energy demand of the heart is primarily met by ATP production from mitochondrial oxidative phosphorylation, with glycolysis providing a smaller amount of ATP production. This ATP production is markedly altered in heart failure, primarily due to a decrease in mitochondrial oxidative metabolism. Although an increase in glycolytic ATP production partly compensates for the decrease in mitochondrial
-
Zebrafish arterial valve development occurs through direct differentiation of second heart field progenitors Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-25 Christopher J Derrick, Lorraine Eley, Ahlam Alqahtani, Deborah J Henderson, Bill Chaudhry
Aims Bicuspid Aortic Valve (BAV) is the most common congenital heart defect, affecting at least 2% of the population. The embryonic origins of BAV remain poorly understood, with few assays for validating patient variants, limiting the identification of causative genes for BAV. In both human and mouse, the left and right leaflets of the arterial valves arise from the outflow tract cushions, with interstitial
-
Tumour necrosis factor receptor-associated factor 7: a new member of the E3 ligase family in cardiac hypertrophy. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-14 Chen Gao,Jinyun Zhu,Ningjing Song,Yibin Wang
-
A hidden role of Th17 cells in doxorubicin-induced cardiac ferroptosis. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-14 Yangfeng Hou,Wentao Gao,Kathy O Lui
-
Dietary salt, vascular dysfunction, and cognitive impairment Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-21 Giuseppe Faraco
Excessive salt consumption is a major health problem worldwide leading to serious cardiovascular events including hypertension, heart disease and stroke. Additionally, high salt diet has been increasingly associated with cognitive impairment in animal models and late-life dementia in humans. High salt consumption is harmful for the cerebral vasculature, disrupts blood supply to the brain and could
-
New insights into the effects of glucagon-like peptide-1 on heart rate and sinoatrial node function. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-14 Simrandeep Kaur,Robert A Rose
-
Mechanisms and consequences of myeloid adhesome dysfunction in atherogenesis Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-12 Irina Zhevlakova, Huan Liu, Tejasvi Dudiki, Detao Gao, Valentin Yakubenko, Svyatoslav Tkachenko, Olga Cherepanova, Eugene A Podrez, Tatiana V Byzova
Aims In the context of atherosclerosis, macrophages exposed to oxidized low-density lipoprotein (oxLDL) exhibit cellular abnormalities, specifically in adhesome functions, yet the mechanisms and implications of these adhesive dysfunctions remain largely unexplored. Methods and Results This study reveals a significant depletion of Kindlin3 (K3) or Fermt3, an essential component of the adhesome regulating
-
Interleukin 11 therapy causes acute left ventricular dysfunction Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-09 Mark Sweeney, Katie O’Fee, Chelsie Villanueva-Hayes, Ekhlas Rahman, Michael Lee, Chung Nga Tam, Eneko Pascual-Navarro, Henrike Maatz, Eric L Lindberg, Konstantinos Vanezis, Chrishan J Ramachandra, Ivan Andrew, Emma R Jennings, Wei-Wen Lim, Anissa A Widjaja, David Carling, Derek J Hausenloy, Norbert Hubner, Paul J R Barton, Stuart A Cook
Aims Interleukin 11 (IL11) was initially thought important for platelet production, which led to recombinant IL11 being developed as a drug to treat thrombocytopenia. IL11 was later found to be redundant for haematopoiesis and its use in patients is associated with unexplained and severe cardiac side effects. Here we aim to identify, for the first time, direct cardiomyocyte toxicities associated with
-
Senescent CD8+ T cells: a novel risk factor in atrial fibrillation Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-09 Xiang Li, Yangyang Bao, Ning Zhang, Changjian Lin, Yun Xie, Yue Wei, Qingzhi Luo, Jingmeng Liu, Zimo Sha, Guanhua Wu, Taojie Zhou, Qiujing Chen, Tianyou Ling, Wenqi Pan, Lin Lu, Liqun Wu, Yang Dai, Qi Jin
Aims Immune cell alterations may play a role in the development of atrial fibrillation (AF). Our objective was to comprehensively characterize immune cells in AF, and investigate the potential mechanisms. Methods and Results Single-cell RNA sequencing and multicolor flow cytometry revealed that T cells constituted the most significant subset alterations in AF, and senescent CD8+ T cells were AF-associated
-
The double-edged impact of obesity on cancer risk and treatment response: implications for atherosclerosis? Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-25 Emiel P C van der Vorst,Mikael Rydén
-
Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-07 Izabela Tuleta, Anis Hanna, Claudio Humeres, Jennifer T Aguilan, Simone Sidoli, Fenglan Zhu, Nikolaos G Frangogiannis
Aims Transforming growth factor (TGF)-β is up-regulated in the diabetic myocardium and may mediate fibroblast activation. We aimed at examining the role of TGF-β-induced fibroblast activation in the pathogenesis of diabetic cardiomyopathy. Methods and results We generated lean and obese db/db mice with fibroblast-specific loss of TbR2, the Type 2 receptor-mediating signaling through all three TGF-β
-
Cellular communication network factor 2 regulates smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-04 Qian Xu,Jisheng Sun,Claire M Holden,Hildebrando Candido Ferreira Neto,Ti Wang,Chiyuan Zhang,Zuli Fu,Giji Joseph,Ruizheng Shi,Jinhu Wang,Andrew Leask,W Robert Taylor,Zhiyong Lin
AIMS Accruing evidence illustrates an emerging paradigm of dynamic vascular smooth muscle cell (SMC) transdifferentiation during atherosclerosis progression. However, the molecular regulators that govern SMC phenotype diversification remain poorly defined. This study aims to elucidate the functional role and underlying mechanisms of cellular communication network factor 2 (CCN2), a matricellular protein
-
Cardiac tumour necrosis factor receptor-associated factor 7 mediates the ubiquitination of apoptosis signal-regulating kinase 1 and aggravates cardiac hypertrophy Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-02 Yan Che, Yu-Ting Liu, Zhao-Peng Wang, Yi-Zhou Feng, Hong-Xia Xia, Yuan Yuan, Heng Zhou, Hong-Liang Qiu, Man-Li Hu, Sha-Sha Wang, Qi-Zhu Tang
Aims Cardiac remodelling is a common pathophysiological process in the development of various cardiovascular diseases, but there is still a lack of effective interventions. Tumour necrosis receptor-associated factor 7 (TRAF7) belongs to the tumour necrosis factor receptor-associated factor family and plays an important role in biological processes. Previous studies have shown that TRAF7 mutations lead
-
The cardiologist in the age of artificial intelligence: what is left for us? Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-25 Thomas F Lüscher,Florian A Wenzl
-
Leveraging metabolism for better outcomes in heart failure Cardiovasc. Res. (IF 10.2) Pub Date : 2024-10-01 Yann Huey Ng, Yen Chin Koay, Francine Z Marques, David M Kaye, John F O’Sullivan
Whilst metabolic inflexibility and substrate constraint have been observed in heart failure for many years, their exact causal role remains controversial. In parallel, many of our fundamental assumptions about cardiac fuel use are now being challenged like never before. For example, the emergence of sodium glucose cotransporter 2 inhibitor (SGLT2i) therapy as one of the four “pillars” of heart failure
-
Renal denervation achieves its antiarrhythmic effect through attenuating macrophage activation and neuroinflammation in stellate ganglia in chronic heart failure Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-25 Wenfeng Hu, Huiyin Tu, Michael C Wadman, Yu-Long Li, Dongze Zhang
Aims Renal denervation (RDN) is widely investigated in multiple studies of sympathetically driven cardiovascular diseases. While the therapeutic potential of RDN for ventricular arrhythmia has been reported, the mechanisms responsible for its antiarrhythmic effect are poorly understood. Our recent study showed that macrophage expansion-induced neuroinflammation in the stellate ganglion (SG) was a critical
-
A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-23 Marie Ouarné, Andreia Pena, Daniela Ramalho, Nadine V Conchinha, Tiago Costa, Romain Enjalbert, Ana M Figueiredo, Marta Pimentel Saraiva, Yulia Carvalho, Miguel O Bernabeu, Lenka Henao Misikova, S Paul Oh, Cláudio A Franco
Aims Arteriovenous malformations (AVMs), a disorder characterized by direct shunts between arteries and veins, are associated with genetic mutations. However, the mechanisms leading to AV shunt formation and how shunts can be reverted are poorly understood. Methods and results Here, we report that oxygen-induced retinopathy (OIR) protocol leads to the consistent and stereotypical formation of AV shunts
-
Hypoxia-responsive zinc finger E-box-binding homeobox 2 (ZEB2) regulates a network of calcium-handling genes in the injured heart Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-23 Monika M Gladka, Arwa Kohela, Anne E de Leeuw, Bas Molenaar, Danielle Versteeg, Lieneke Kooijman, Mariska van Geldorp, Willem B van Ham, Rocco Caliandro, Jody J Haigh, Toon A B van Veen, Eva van Rooij
Aims Intracellular calcium (Ca2+) overload is known to play a critical role in the development of cardiac dysfunction. Despite the remarkable improvement in managing the progression of heart disease, developing effective therapies for heart failure (HF) remains a challenge. A better understanding of molecular mechanisms that maintain proper Ca2+ levels and contractility in the injured heart could be
-
Spatiotemporal EP4–fibulin-1 expression is associated with vascular intimal hyperplasia Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-21 Shigekuni Okumura, Sayuki Oka, Takako Sasaki, Marion A Cooley, Yuko Hidaka, Hana Inoue, Hitoshi Nishijima, Shin-Ichiro Ohno, Shota Tanifuji, Mari Kaneko, Takaya Abe, Masahiko Kuroda, Tadashi Yokosuka, Richard M Breyer, Hiroshi Homma, Yuko Kato, Utako Yokoyama
Aims Cyclooxygenase-2–derived prostaglandin E2 (PGE2) is thought to promote vascular intimal hyperplasia (IH). It has been reported that the PGE2 receptor EP4 is upregulated in injured vessels and that EP4 signalling in vascular smooth muscle cells (VSMCs) promotes IH. In contrast, EP4 in endothelial cells has been demonstrated to restrain IH. We aimed to investigate spatiotemporal expression of EP4
-
How far are we from accurate sex-specific risk prediction of cardiovascular disease? One size may not fit all. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-21 Bi Huang,Mayank Dalakoti,Gregory Y H Lip
-
Gene therapy for cardiac diseases: methods, challenges, and future directions Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-20 Luca Grisorio, Rossana Bongianino, Matteo Gianeselli, Silvia Giuliana Priori
Gene therapy is advancing at an unprecedented pace, and the recent success of clinical trials reinforces optimism and trust among the scientific community. Recently, the cardiac gene therapy pipeline, which had progressed more slowly than in other fields, has begun to advance, overcoming biological and technical challenges, particularly in treating genetic heart pathologies. The primary rationale behind
-
GDF15 antagonism limits severe heart failure and prevents cardiac cachexia Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-19 Minoru Takaoka, John A Tadross, Ali B A K Al-Hadithi, Xiaohui Zhao, Rocío Villena-Gutiérrez, Jasper Tromp, Shazia Absar, Marcus Au, James Harrison, Anthony P Coll, Stefan J Marciniak, Debra Rimmington, Eduardo Oliver, Borja Ibáñez, Adriaan A Voors, Stephen O’Rahilly, Ziad Mallat, Jane C Goodall
Aims Heart failure and associated cachexia is an unresolved and important problem. This study aimed to determine the factors that contribute to cardiac cachexia in a new model of heart failure in mice that lack the integrated stress response (ISR) induced eIF2α phosphatase, PPP1R15A. Methods and results Mice were irradiated and reconstituted with bone marrow cells. Mice lacking functional PPP1R15A
-
Interleukin-12p40 deficiency attenuates myocardial ferroptosis in doxorubicin-induced chronic cardiomyopathy by inhibiting Th17 differentiation and interleukin-17A production Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-19 Jishou Zhang, Wen Ding, Zheng Yin, Siqi Liu, Mengmeng Zhao, Yao Xu, Jianfang Liu, Wei Pan, Shanshan Peng, Cheng Wei, Zihui Zheng, Juan-Juan Qin, Jun Wan, Menglong Wang
Aims Interleukin (IL)-12p40 is a common subunit of the bioactive cytokines IL-12 and IL-23, and it also has its own intrinsic functional activity. However, its role in doxorubicin-induced chronic cardiomyopathy (DICCM) as well as the underlying mechanisms are still unknown. Methods and Results In this study, we used IL-12p40-knockout mice, IL-23p19-knockout mice, Rag1-knockout mice, a ferroptosis inhibitor
-
Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-18 Wei Zhang, Yan Zhang, Liping Han, Tao Bo, Zhiyong Qi, Haoxuan Zhong, Huajie Xu, Liang Hu, She Chen, Si Zhang
Aims Elevated dsDNA levels in STEMI patients are associated with increased infarct size and worse clinical outcomes. However, the direct effect of dsDNA on platelet activation remains unclear. This study aims to investigate the direct influence of dsDNA on platelet activation, thrombosis, and the underlying mechanisms. Methods and Results Analysis of clinical samples revealed elevated plasma dsDNA
-
Activation of β3-AR by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-17 Ze-Bei Zhang, Yu-Wen Cheng, Lian Xu, Jia-Qi Li, Xin Pan, Min Zhu, Xiao-Hui Chen, Ai-Jun Sun, Jing-Rong Lin, Ping-Jin Gao
Aims β3-AR (β3-adrenergic receptor) is essential for cardiovascular homeostasis through regulating adipose tissue function. Perivascular adipose tissue (PVAT) has been implicated in the pathogenesis of aortic dissection and aneurysm (AD/AA). Here, we aim to investigate β3-AR activation-mediated PVAT function in AD/AA. Methods and Results Aortas from patients with thoracic aortic dissection (TAD) were
-
Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-17 Alwin Tubben, George Markousis-Mavrogenis, Laura M G Meems, Bart J van Essen, Lukas Baumhove, Milou Berends, Hendrea S A Tingen, Johan Bijzet, Bouke P C Hazenberg, Adriaan A Voors, Dirk J van Veldhuisen, Riemer H J A Slart, Hans L A Nienhuis, Peter van der Meer
Aims Wild-type transthyretin cardiac amyloidosis (ATTRwt-CM) is an under-recognized aetiology of heart failure (HF), necessitating early detection for timely treatment. Our study aimed to differentiate patients with ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF patients by identifying and validating circulating protein biomarkers. In addition, we measured the same biomarkers in patients with cardiomyopathy
-
Abnormal circadian rhythms exacerbate dilated cardiomyopathy by reducing the ventricular mechanical strength Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-14 Hao Jia, Hao Cui, Zijie Zhao, Han Mo, Ningning Zhang, Yu Zhang, Siyuan Huang, Yue Zhang, Mengda Xu, Lei Han, Yulin Chen, Yuan Chang, Xiumeng Hua, Zhibo Shentu, Tie Xia, Xiao Chen, Jiangping Song
Aims Dilated cardiomyopathy (DCM) has etiological and pathophysiological heterogeneity. Abnormal circadian rhythm (ACR) is related to the development of DCM in animal models, but exploration based on clinical samples is lacking. Sleep apnea (SA) is the most common disease related to ACR, and we chose SA as the study object to explore ACR-DCM. Methods and results We included a derivation cohort (n =105)
-
Olfr2+ macrophages: monocyte-derived, pro-inflammatory foamy-like cells in atherosclerosis. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-05 Clément Cochain,Alma Zernecke
-
When bigger is better: utilizing large animal models in vein graft surgery to gain insights into endothelial-to-mesenchymal transition. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-25 Clarissa Becher,Marie-José Goumans,Gonzalo Sanchez-Duffhues
-
Uncovering vascular signature of sphingosine-1-phosphate receptor 1 activation. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-11-25 Ewelina Józefczuk,Mateusz Siedlinski
-
Cardiac automaticity is modulated by IKACh in sinoatrial node during pregnancy Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-11 Valérie Long, Gracia El Gebeily, Élisabeth Leblanc, Marwa Senhadji, Céline Fiset
Aims Pregnant women have a significantly elevated resting heart rate (HR), which makes cardiac arrhythmias more likely to occur. Although electrical remodeling of the sinoatrial node (SAN) has been documented, the underlying mechanism is not fully understood. The acetylcholine-activated potassium current (IKACh), one of the major repolarizing currents in the SAN, plays a critical role in HR control
-
Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-11 Melanie Modder, Wietse In het Panhuis, Mohan Li, Salwa Afkir, Alexandra L Dorn, Amanda C M Pronk, Trea C M Streefland, Reshma A Lalai, Stefan Pierrou, Stefan K Nilsson, Gunilla Olivecrona, Sander Kooijman, Patrick C N Rensen, Milena Schönke
Background and Aims Angiopoietin-like 3 (ANGPTL3) and 4 (ANGPTL4) inhibit lipoprotein lipase to regulate tissue fatty acid uptake from triglyceride-rich lipoproteins such as VLDL. While pharmacological inhibition of ANGPTL3 is being evaluated as lipid-lowering strategy, systemic ANGPTL4 inhibition is not pursued due to adverse effects. This study aimed to compare the therapeutic potential of liver-specific
-
Endothelial estrogen - myocardial cGMP axis critically determines angiogenesis and cardiac performance during pressure-overload Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-10 Nobuaki Fukuma, Hiroyuki Tokiwa, Genri Numata, Kazutaka Ueda, Pangyen Liu, Miyu Tajima, Yu Otsu, Taro Kariya, Yukio Hiroi, James K Liao, Issei Komuro, Eiki Takimoto
Aim Estrogen exerts beneficial cardiovascular effects by binding to specific receptors on various cells to activate nuclear and non-nuclear actions. Estrogen receptor α (ERα) non-nuclear signaling confers protection against heart failure remodeling, involving myocardial cyclic guanosine monophosphate (cGMP) - cGMP-dependent protein kinase G (PKG) activation; however, its tissue-specific role remains